Since both LncRNA ADAMTS9-AS2 and miR-223-3p participated in the regulation of resistance of cancer cells to chemotherapeutic drugs [25, 37], further experiments were conducted to explore the role of LncRNA ADAMTS9-AS2/miR-223-3p axis in the modulation of cisplatin-resistance in GC cells. This evidence concerns the gene ADAMTS9 and cancer.